Michael S Leapman (Michael Leapman)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Machine Learning

Radical Prostatectomy

Top Venues

JNCI cancer spectrum

Current urology reports

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriela M Diaz, Lindsey T Webb, Maximilian J Rabil, Soum D Lokeshwar, Ankur U Choksi, Michael S Leapman, Preston C Sprenkle
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy. Current urology reports 25 (10) (2024)
Gabriela M Diaz, Lindsey T Webb, Maximilian J Rabil, Soum D Lokeshwar, Ankur U Choksi, Michael S Leapman, Preston C Sprenkle
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy. Current urology reports (2024)
Ryan Sutherland, Cary P Gross, Xiaomei Ma, Farah Jeong, Tyler M Seibert, Matthew R Cooperberg, William J Catalona, Shellie D Ellis, Stacy Loeb, Dena Schulman-Green, Michael S Leapman
'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer. BJUI compass 5 (6) (2024)
Ryan Sutherland, Cary P Gross, Xiaomei Ma, Farah Jeong, Tyler M Seibert, Matthew R Cooperberg, William J Catalona, Shellie D Ellis, Stacy Loeb, Dena Schulman-Green, Michael S Leapman
'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer. BJUI compass 5 (6) (2024)
Victoria A Marks, Walter R Hsiang, James Nie, Waez Umer, Afash Haleem, Bayan Galal, Irene Pak, Dana Kim, Michelle C Salazar, Haddon Pantel, Elizabeth R Berger, Daniel J Boffa, Jaime A Cavallo, Michael S Leapman
Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional Study. JMIR cancer 9 (2023)
Michael S Leapman, Ryan Sutherland, Cary P Gross, Xiaomei Ma, Tyler M Seibert, Matthew R Cooperberg, William J Catalona, Stacy Loeb, Dena Schulman-Green
Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. BJUI compass 5 (1) (2023)
Michael S Leapman, Stacy Loeb, Matthew R Cooperberg, William J Catalona, Franklin D Gaylis
A vision for closing the evidence-practice gap in the management of low-grade prostate cancer. JNCI cancer spectrum 7 (2) (2023)
Michael S Leapman, Stacy Loeb, Matthew R Cooperberg, William J Catalona, Franklin D Gaylis
A vision for closing the evidence-practice gap in the management of low-grade prostate cancer. JNCI cancer spectrum 7 (2) (2023)
Michael S Leapman, Stacy Loeb, Matthew R Cooperberg, William J Catalona, Franklin D Gaylis
A vision for closing the evidence-practice gap in the management of low-grade prostate cancer. JNCI cancer spectrum 7 (2) (2023)
Michael S Leapman, Ryan Sutherland, Cary P Gross, Xiaomei Ma, Tyler M Seibert, Matthew R Cooperberg, William J Catalona, Stacy Loeb, Dena Schulman-Green
Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. BJUI compass 5 (1) (2023)
Michael S Leapman, Ryan Sutherland, Cary P Gross, Xiaomei Ma, Tyler M Seibert, Matthew R Cooperberg, William J Catalona, Stacy Loeb, Dena Schulman-Green
Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. BJUI compass 5 (1) (2023)
Michael S Leapman, Ryan Sutherland, Cary P Gross, Xiaomei Ma, Tyler M Seibert, Matthew R Cooperberg, William J Catalona, Stacy Loeb, Dena Schulman-Green
Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. BJUI compass 5 (1) (2023)
Nathan Paulson, Tal Zeevi, Maria Papademetris, Michael S Leapman, John A Onofrey, Preston C Sprenkle, Peter A Humphrey, Lawrence H Staib, Angelique W Levi
Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine Learning. JCO clinical cancer informatics 6 (2022)
Hannah E Dzimitrowicz, Lauren E Wilson, Bradford E Jackson, Lisa P Spees, Christopher D Baggett, Melissa A Greiner, Deborah R Kaye, Tian Zhang, Daniel J George, Charles D Scales, Jessica E Pritchard, Michael S Leapman, Cary P Gross, Michaela A Dinan, Stephanie B Wheeler
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy. JCO oncology practice (2022)
Nathan M Shaw, Nizar Hakam, Jason L Lui, Behzad Abbasi, Architha Sudhakar, Michael S Leapman, Benjamin N Breyer
COVID-19 Misinformation and Social Network Crowdfunding: Cross-sectional Study of Alternative Treatments and Antivaccine Mandates. Journal of medical Internet research 24 (7) (2022)
Ilyssa O Gordon, Jodi D Sherman, Michael S Leapman, Michael Overcash, Cassandra L Thiel
Life Cycle Greenhouse Gas Emissions of Gastrointestinal Biopsies in a Surgical Pathology Laboratory. American journal of clinical pathology 156 (4) (2021)
Pawel Rajwa, Jamil Syed, Michael S Leapman
How should radiologists incorporate non-imaging prostate cancer biomarkers into daily practice? Abdominal radiology (New York) 45 (12) (2021)
Gregory C McMahon, Michael S Leapman
A disease by any other name: Effects of cancer grading nomenclature on perception of prostate cancer risk. Cancer 127 (18) (2021)